These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11382949)

  • 1. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.
    Ikeda DM; Hylton NM; Kinkel K; Hochman MG; Kuhl CK; Kaiser WA; Weinreb JC; Smazal SF; Degani H; Viehweg P; Barclay J; Schnall MD
    J Magn Reson Imaging; 2001 Jun; 13(6):889-95. PubMed ID: 11382949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement.
    Radovic N; Ivanac G; Divjak E; Biondic I; Bulum A; Brkljacic B
    J Magn Reson Imaging; 2019 May; 49(5):1381-1390. PubMed ID: 30325549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
    El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
    Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast imaging reporting and data system standardized mammography lexicon: observer variability in lesion description.
    Baker JA; Kornguth PJ; Floyd CE
    AJR Am J Roentgenol; 1996 Apr; 166(4):773-8. PubMed ID: 8610547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers.
    Kishimoto AO; Kataoka M; Iima M; Honda M; Miyake KK; Ohashi A; Ota R; Kataoka T; Sakurai T; Toi M; Togashi K
    Magn Reson Imaging; 2020 Sep; 71():161-169. PubMed ID: 32320723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BI-RADS breast magnetic resonance imaging lexicon.
    Molleran V; Mahoney MC
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):171-85, vii. PubMed ID: 20494304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
    Kim SJ; Morris EA; Liberman L; Ballon DJ; La Trenta LR; Hadar O; Abramson A; Dershaw DD
    AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast imaging reporting and data system lexicon for US: interobserver agreement for assessment of breast masses.
    Abdullah N; Mesurolle B; El-Khoury M; Kao E
    Radiology; 2009 Sep; 252(3):665-72. PubMed ID: 19567644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress report from the American College of Radiology Breast MR Imaging Lexicon Committee.
    Ikeda DM
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):295-302, vi. PubMed ID: 11493420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rim-enhancing breast masses with smooth or spiculated margins on magnetic resonance imaging: histopathology and clinical significance.
    Uematsu T; Kasami M; Nicholson BT
    Jpn J Radiol; 2011 Nov; 29(9):609-14. PubMed ID: 21956365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observer agreement using the ACR Breast Imaging Reporting and Data System (BI-RADS)-ultrasound, First Edition (2003).
    Park CS; Lee JH; Yim HW; Kang BJ; Kim HS; Jung JI; Jung NY; Kim SH
    Korean J Radiol; 2007; 8(5):397-402. PubMed ID: 17923782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography?
    Kamal RM; Helal MH; Mansour SM; Haggag MA; Nada OM; Farahat IG; Alieldin NH
    Br J Radiol; 2016 Aug; 89(1064):20160157. PubMed ID: 27327403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging.
    Stoutjesdijk MJ; Fütterer JJ; Boetes C; van Die LE; Jager G; Barentsz JO
    Invest Radiol; 2005 Jun; 40(6):355-62. PubMed ID: 15905722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon.
    Agrawal G; Su MY; Nalcioglu O; Feig SA; Chen JH
    Cancer; 2009 Apr; 115(7):1363-80. PubMed ID: 19197974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
    Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
    Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.
    Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM
    J Comput Assist Tomogr; 2018; 42(1):155-161. PubMed ID: 28806321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.